It is essential to understand the cumulative effect of GLP-1 RAs on the quality of bowel preparation to be able to guide patients and better understand the appropriate measures and counseling that need to be taken before undergoing colonoscopies
While 503B facilities are required to follow current Good Manufacturing Practices (cGMP), the compounded drugs themselves are not FDA-approved. If semaglutide and tirzepatide are removed from the 503B bulks list, the availability of compounded GLP-1s would drop significantly, Michael Snyder, MD, FACS, FASMBS, DABOM, medical director of the Bariatric Surgery Center at Rose Medical Center, founder and director of the Denver Center for Bariatric Surgery Foundation, and in-house obesity specialist at FuturHealth, told MNT
Liposomal liquid supplements often benefit from refrigeration after opening to preserve stability, but the specific requirement will be stated by the manufacturer on the label
[4] [10] The phase 2 data demonstrated substantial weight loss up to 24.2% of body weight at the highest dose over 48 weeks alongside improvements in glycaemic control, making it one of the most efficacious agents studied to date in this class